joe__winer Profile Banner
Joe Winer Profile
Joe Winer

@joe__winer

Followers
907
Following
3K
Media
40
Statuses
469

neuroscientist studying sleep and memory in the aging brain | instructor at Stanford

San Francisco, CA
Joined January 2018
Don't wanna be here? Send us removal request.
@joe__winer
Joe Winer
7 months
RT @YueLengsleep: Very excited to share our new findings on REM sleep latency and AD biomarkers🧠 - REM #sleep is more than a #DREAM! Speci….
0
20
0
@joe__winer
Joe Winer
1 year
We are šŸ“¢hiringšŸ“¢ a research coordinator in the @MorminoLab at Stanford to work on exciting new sleep and aging projects!
Tweet card summary image
careersearch.stanford.edu
The Mormino Lab within the Department of Neurology and Neurological Sciences is seeking a Clinical Research Coordinator Associate (CRCA) to work on...
0
21
37
@grok
Grok
3 days
Join millions who have switched to Grok.
156
294
2K
@joe__winer
Joe Winer
1 year
It’s Tuesday in Philadelphia and we’re at Poster 490 talking about Sleep and Alzheimer’s disease we have some interesting results so come out and hear about it!
Tweet media one
2
5
67
@joe__winer
Joe Winer
1 year
Very excited about Alex’s poster relating actigraphy-measured sleep with self reported next-day sleep quality. More to come soon from this project!!.
@MorminoLab
Mormino Lab
1 year
@alex___washburn presenting his work on sleep in AD and LBD 😓+ Alex and his mentor, @joe__winer at #AAIC24 šŸ’œšŸ§ 
Tweet media one
Tweet media two
0
1
14
@joe__winer
Joe Winer
1 year
RT @MorminoLab: Check out the #MorminoLab posters tomorrow at #AAIC24, with work from @pddoc🩸, @ClaireD_MD🧬, and @joe__winer😓 @alzassociati….
0
7
0
@joe__winer
Joe Winer
1 year
RT @MorminoLab: šŸ‘šŸ»BravošŸ‘šŸ» to @joe__winer for a tremendous presentation to close out the ā€œNeuroimaging Correlates of Risk and Protective Fac….
0
4
0
@joe__winer
Joe Winer
1 year
I am thrilled and very grateful that our project collecting and sharing actigraphy data across ADRCs has been selected by @NACCData! We are very excited to get started!.
@NACCData
National Alzheimer's Coordinating Center (NACC)
1 year
Please join us in congratulating this year's two awardees for the inaugural @naccdata and Gates Ventures AD/ADRD Digital Data Pilot Program! We are eager to see how these emerging digital solutions and digital data collection will transform AD/ADRD discovery and translation!
Tweet media one
5
6
56
@joe__winer
Joe Winer
1 year
RT @StanfordADRC: In @nytimes featuring our very own @joe__winer: "How Sleep Affects Your Risk of Dementia." For older adults, too much or….
nytimes.com
For older adults, too much or too little sleep has been tied to cognitive issues.
0
2
0
@joe__winer
Joe Winer
1 year
This is a really nice study showing (small) elevations in Alzheimer's and neurodegeneration biomarkers in the evening versus the morning. Toxicity of wakefulness! 🤪.
@biofinder_study
BioFINDER
1 year
🚨New paper out led by PhD Student @A_OrdunaDolado ā€¼ļø."Effect of time of the day at sampling on CSF and plasma levels of Alzheimer’s Disease biomarkersā€ now on @AlzheimersRes!.
4
0
25
@joe__winer
Joe Winer
1 year
Thrilled to be pitching (LIVE!) our pilot proposal to @NACCData @gatesfoundation on 5/31. We want to collect harmonized sleep and activity data across the NACC/ADRC network and make it freely available to researchers everywhere!.
@NACCData
National Alzheimer's Coordinating Center (NACC)
1 year
Congrats to the 6 teams competing for $250K - $1M in funding at the virtual pitch competition for the NACC/Gates Ventures AD/ADRD Digital Pilot Program! Join us in cheering on these teams May 31 at 1:00–3:30pm ET. Register today, all are welcome:
Tweet media one
2
2
32
@joe__winer
Joe Winer
1 year
The evidence is better, I think, that extended *wake* leads to elevated production of amyloid and tau. One benefit of sleep may be to give the brain a break from the toxicity of wakefulness.
4
0
14
@joe__winer
Joe Winer
1 year
My experience talking about sleep in the aging and Alzheimer's field is that many take for granted sleep = waste clearance. But the evidence has been limited to a handful of studies, almost all in mice. This study is important evidence for reconsidering the role of sleep.
@NatureNeuro
Nature Neuroscience
1 year
Brain clearance is markedly reduced, not increased, during #sleep and #anesthesia in male mice.
4
8
53
@joe__winer
Joe Winer
2 years
RT @MorminoLab: Interested in healthy aging? Memory mechanisms? Neuroimaging? Want to gain experience before applying to grad school? We ar….
Tweet card summary image
careersearch.stanford.edu
The Mormino Laboratory within the Department of Neurology and Neurological Sciences is seeking a Clinical Research Coordinator Associates (CRCA) to...
0
20
0
@joe__winer
Joe Winer
2 years
Our paper on impaired sleep-wake rhythms predicting future Alzheimer's, Parkinson's, and cognitive decline in the UK Biobank actigraphy cohort (N=82,829!) is out now in @AlzheimersRes ! āŒšļøšŸ˜“šŸƒā€ā™€ļøšŸ§ 
Tweet card summary image
alzres.biomedcentral.com
Background Sleep-wake regulating circuits are affected during prodromal stages in the pathological progression of both Alzheimer’s disease (AD) and Parkinson’s disease (PD), and this disturbance can...
0
21
98
@joe__winer
Joe Winer
2 years
thrilled for another year of manatees and PET imaging @HAIconference with @MorminoLab
Tweet media one
Tweet media two
3
0
24
@joe__winer
Joe Winer
2 years
RT @Prof_Naismith: If you work in sleep/AD research, have your say! Complete our Delphi survey for consensus recommendations on sleep/circa….
0
6
0
@joe__winer
Joe Winer
2 years
RT @VVyazovskiy: Penguins snatch seconds-long microsleeps | Science
Tweet card summary image
science.org
Chinstrap penguins fall asleep thousands of times per day in the wild
0
11
0
@joe__winer
Joe Winer
2 years
Check out Dino's (@leonardinosaur) excellent and important new piece on anti-amyloid therapies, written with Mike Greicius.
@leonardinosaur
Leonardino (Dino) Digma
2 years
With #CTAD23 happening, it is an exciting week for the AD field. To contribute to the discussion, we (I, @joe__winer, and Mike Greicius) wanted to highlight three observations regarding recent anti-amyloid clinical trials:.
0
2
13